Vivek Subbiah, MD ✓

@VivekSubbiah · Nashville, TN, USA · joined 11 Mar 2015

Drug Development| Precision Oncology| Tissue-Agnostic Precision Medicine #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.

41 191Followers

2 204Following

30 376Posts total

17.7KViews on collected posts

Postingan terbaru

Vivek Subbiah, MD ✓@VivekSubbiah13 Sep

⭐️🚨Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy | New England Journal of Medicine https://t.co/Eip8eT6lbk 592 views · 3 likes · 2 reposts · 1 replies Open on X →

Vivek Subbiah, MD ✓@VivekSubbiah11 Sep

⭐️Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy | New England Journal of Medicine https://t.co/qYTX2VD3de 2.1K views · 27 likes · 5 reposts · 3 replies Open on X →

Vivek Subbiah, MD ✓@VivekSubbiah8 Sep

🚨FDA names acting heads of drug and vaccine centers to permanent roles https://t.co/czNIPaHW4V via @statnews 1.6K views · 6 likes · 0 reposts · 1 replies Open on X →

Vivek Subbiah, MD ✓@VivekSubbiah27 Aug

ChatGPT has given me glasses- apparently that’s the minimum requirement to look scholarly 🤓 Thanks for including me @BalazsHalmosMD @PTarantinoMD but where is my share of baklava ? @chadinabhan @PGrivasMDPhD 2.3K views · 10 likes · 0 reposts · 3 replies Open on X →

Vivek Subbiah, MD ✓@VivekSubbiah27 Aug

Applications for 2026 Young Investigator Awards Are Closing on September 10 - Conquer Cancer - OncoDaily https://t.co/2j1r892lgV 1.4K views · 6 likes · 4 reposts · 0 replies Open on X →

Vivek Subbiah, MD ✓@VivekSubbiah25 Aug

@gachanta @PTarantinoMD @StephenVLiu @PGrivasMDPhD @NarjustFlorezMD @Dr_AmerZeidan @DrChoueiri How ChatGPT pictures “The Pitt” https://t.co/sMbKuGBfd0

9.7K views · 13 likes · 3 reposts · 2 replies Open on X →

Dibandingkan akun berukuran sama

6 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. jangkauan biasa untuk ukurannya, reaksi lebih lemah dari kebanyakan.

Median tayangan1 824akun ini959median untuk 10K–100K

Jangkauan, %4.43%akun ini3.75%median untuk 10K–100K

Interaksi, %0.63%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	1 824	959	1.90×
Jangkauan (tayangan ÷ pengikut)	4.43%	3.75%	1.18×
Tingkat interaksi	0.63%	1.52%	0.41×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

9.7K25 Aug

1.4K27 Aug

2.3K

1.6K8 Sep

2.1K11 Sep

59213 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.18%25 Aug

0.70%27 Aug

0.56%

0.44%8 Sep

1.70%11 Sep

1.01%13 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.4%65 in total

Reposts13.9%14 in total

Replies9.9%10 in total

Bookmarks11.9%12 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

8 Sep

Daily snapshots since 08 Sep 2026; the dashed line is the starting count.